CSPC Innovation Pharmaceutical Co Ltd Class A Total Assets
CSPC Innovation Pharmaceutical Co Ltd Class A total assets. Based on the latest financial reports, CSPC Innovation Pharmaceutical Co Ltd Class A (300765) holds total assets worth CN¥6.21 Billion CNY (≈ $908.72 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of CSPC Innovation Pharmaceutical Co Ltd Cl for the company's overall valuation and market capitalisation.
Total Assets of CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)
Total assets of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's total assets have evolved over time, based on quarterly financial data. See today's stock price for CSPC Innovation Pharmaceutical Co Ltd Cl for real-time trading data and today's change.
CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Composition Analysis
CSPC Innovation Pharmaceutical Co Ltd Class A Total Assets Breakdown (December 2025)
CSPC Innovation Pharmaceutical Co Ltd Class A total assets breakdown as of December 2025. CSPC Innovation Pharmaceutical Co Ltd Class A's total assets of CN¥6.21 Billion consist of 45.5% current assets and 54.5% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.3% |
| Accounts Receivable | CN¥704.16 Million | 11.2% |
| Inventory | CN¥497.80 Million | 7.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥218.85 Million | 3.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CSPC Innovation Pharmaceutical Co Ltd Cl short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CSPC Innovation Pharmaceutical Co Ltd Class A's current assets represent 45.5% of total assets in 2025, a decrease from 60.0% in 2014.
- Cash Position: Cash and equivalents constituted 12.3% of total assets in 2025, down from 16.1% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 6.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 11.2% of total assets.
CSPC Innovation Pharmaceutical Co Ltd Class A Competitors by Total Assets
Key competitors of CSPC Innovation Pharmaceutical Co Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF128.38 Billion |
|
The Magnum Ice Cream Company N.V.
AS:MICC
|
Netherlands | €7.49 Billion |
|
COFCO Tunhe Sugar Co Ltd
SHG:600737
|
China | CN¥22.01 Billion |
|
The a2 Milk Company Ltd
AU:A2M
|
Australia | AU$1.96 Billion |
|
Lotus Health Group Co
SHG:600186
|
China | CN¥3.86 Billion |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
Mexico | MX$48.32 Billion |
|
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086
|
China | CN¥1.59 Billion |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
China | CN¥4.18 Billion |
CSPC Innovation Pharmaceutical Co Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 1.77 | 9.82 |
| Quick Ratio | 0.83 | 1.51 | 9.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-2.04 Million | CN¥1.24 Billion | CN¥1.93 Billion |
CSPC Innovation Pharmaceutical Co Ltd Class A - Advanced Valuation Insights
This section examines the relationship between CSPC Innovation Pharmaceutical Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 17.48 |
| Latest Market Cap to Assets Ratio | 0.97 |
| Asset Growth Rate (YoY) | 4.2% |
| Total Assets | CN¥6.28 Billion |
| Market Capitalization | $6.11 Billion USD |
Valuation Analysis
Near Book Valuation: The market values CSPC Innovation Pharmaceutical Co Ltd Class A's assets close to their book value (0.97x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: CSPC Innovation Pharmaceutical Co Ltd Class A's assets grew by 4.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)
The table below shows the annual total assets of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.28 Billion ≈ $918.42 Million |
+4.22% |
| 2024-12-31 | CN¥6.02 Billion ≈ $881.22 Million |
-19.41% |
| 2023-12-31 | CN¥7.47 Billion ≈ $1.09 Billion |
+63.01% |
| 2022-12-31 | CN¥4.58 Billion ≈ $670.79 Million |
+22.53% |
| 2021-12-31 | CN¥3.74 Billion ≈ $547.46 Million |
+26.54% |
| 2020-12-31 | CN¥2.96 Billion ≈ $432.64 Million |
+3.65% |
| 2019-12-31 | CN¥2.85 Billion ≈ $417.39 Million |
+105.09% |
| 2018-12-31 | CN¥1.39 Billion ≈ $203.52 Million |
+23.18% |
| 2017-12-31 | CN¥1.13 Billion ≈ $165.22 Million |
+16.56% |
| 2016-12-31 | CN¥968.68 Million ≈ $141.75 Million |
+1.22% |
| 2015-12-31 | CN¥957.02 Million ≈ $140.04 Million |
+15.05% |
| 2014-12-31 | CN¥831.82 Million ≈ $121.72 Million |
-- |
About CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more